Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CYB pseudogene 41 (MTCYBP41), also known as mitochondrially encoded cytochrome b pseudogene 41, refers to a pseudogene related to the MT-CYB gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically result from gene duplication or retrotransposition events. Unlike the functional MT-CYB gene—which encodes cytochrome b, a critical component of mitochondrial respiratory chain complex III and is associated with diverse mitochondrial disorders—MTCYBP41 does not produce a functional protein and has no known biological function or disease association. It is not a therapeutic target, receptor, enzyme, or clinical biomarker. The designation may appear in some genome annotations, but its role is limited to being a noncoding genetic element, not an actionable drug target or disease gene[4].\n\n**Essential context and supporting details:**\n- The canonical MT-CYB gene (not the pseudogene) encodes mitochondrial cytochrome b, essential for mitochondrial electron transport and ATP production[1][5][3][8].\n- MT-CYB pseudogenes, like MTCYBP41, are cataloged in genomic databases but lack function, expression, or known clinical significance[4].\n- The MT-CYB protein and its true gene (not pseudogene) are associated with mitochondrial complex III deficiency, cardiomyopathy, and certain mitochondrial diseases, but this does not apply to its pseudogenes[1][5][3].\n- Pseudogenes are not considered drug targets, do not interact with approved drugs, and do not have roles in therapeutic intervention.\n\n**Summary:** \nMT-CYB pseudogene 41 (MTCYBP41) is a non-functional pseudogene with no biological or therapeutic role. There is no evidence for disease association, drug interaction, or functional protein product, and this entry is not a targetable molecule. Its inclusion as a target is incorrect[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CYB pseudogene 41 (MTCYBP41).